A low supply of estrogen patches has some Alberta women scrambling to find alternative treatments for menopause symptoms. On Nov. 4, Health Canada issued a supply chain notice after classifying estrogen transdermal patches as a Tier 3 shortage on Oct. 28. In Canada, Bayer Inc. and Sandoz Canada are facing supply shortages of their patches, impacting access to Climara Estalis, Estradot and Estradiol Derm. Health Canada said it will be difficult to get these, likely until early 2027. Until then, patients might find relief from different types of patches, gels or pills. Doctors say the alternatives aren’t always ideal, but treating hot flashes, insomnia and fatigue is key. “Controlling the symptoms is quite significant,” said obstetrician and gynecologist Dr. Angela Vinturache. “It improves the quality of life so she can work, she can function (and) she can take care of her family.” Health Canada said the shortages are from global supply challenges, partly due to disruptions in manufacturing but also because of increased demand. Though widely underfunded and understudied, awareness about menopause is now rising. The use of menopausal hormone therapy in Canada increased by 29 per cent between 2017 and 2023, according to a study published in the Menopause Society in October 2026. “Definitely an increased interest in having a patch as a simple and easy treatment, and we would hope that, like anything else, when people would like that, when there’s demand, that supply will be met,” said Kimberley Simmonds, CEO of Primary Care Alberta. Health-care toll Finding alternatives can involve a lot of trial and error with varying effects, which adds to the toll for everyone involved. “It makes it problematic for patients, and it’s problematic for the providers that people have to go back to and for pharmacists,” said Simmonds, who indicated providers are doing their best to work together to find solutions. “Altogether that creates a burden on the healthcare system,” said Vinturache, adding patients might need time off work for more appointments and doctors and pharmacists need to spend more time finding alternatives after already finding options that work well for patients. Once an alternative is found, there’s no indication if it might also face shortages. It has been hard to get some estrogen patches for months, but as patients turned to alternatives, supply concerns expanded to other brands, prompting the Health Canada shortage and supply warning. Kristin’s Story Kristin Bonneville is a mother and runs her own real estate photography business in Grande Prairie, so no longer having access to the treatment she was using for her menopause symptoms is challenging. “If you find something that works and it’s not available, that impacts your life, right? (It’s) integral to sleep, performance, energy, brain fog,” said Bonneville. Bonneville says the alternatives she tried aren’t as good as her old medication, and they haven’t all worked, which means more time dealing with symptoms and in appointments. “It is frustrating. … We just want to be our best in our jobs for our families,” she said. She hopes increased awareness and demand for hormone therapies will soon provide consistency so women can focus on their lives.